Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.
press the down arrow to open sub-menu.
2019
Active
Principal Investigators: Stevan Hubbard, PhD
Ajax Therapeutics is a biotech company that develops precision therapies for blood cancers called myeloproliferative neoplasms (MPNs). They use computational chemistry and structural biology to create highly selective therapies that target specific proteins involved in the development of MPNs. Ajax aims to improve treatment efficacy and reduce side effects for MPN patients.